Suppr超能文献

用于治疗腰椎间盘突出症的微创手术方法。

Minimally invasive surgical procedures for the treatment of lumbar disc herniation.

作者信息

Lühmann Dagmar, Burkhardt-Hammer Tatjana, Borowski Cathleen, Raspe Heiner

机构信息

Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Institut für Sozialmedizin, Lübeck, Deutschland.

出版信息

GMS Health Technol Assess. 2005 Nov 15;1:Doc07.

Abstract

INTRODUCTION

In up to 30% of patients undergoing lumbar disc surgery for herniated or protruded discs outcomes are judged unfavourable. Over the last decades this problem has stimulated the development of a number of minimally-invasive operative procedures. The aim is to relieve pressure from compromised nerve roots by mechanically removing, dissolving or evaporating disc material while leaving bony structures and surrounding tissues as intact as possible. In Germany, there is hardly any utilisation data for these new procedures - data files from the statutory health insurances demonstrate that about 5% of all lumbar disc surgeries are performed using minimally-invasive techniques. Their real proportion is thought to be much higher because many procedures are offered by private hospitals and surgeries and are paid by private health insurers or patients themselves. So far no comprehensive assessment comparing efficacy, safety, effectiveness and cost-effectiveness of minimally-invasive lumbar disc surgery to standard procedures (microdiscectomy, open discectomy) which could serve as a basis for coverage decisions, has been published in Germany.

OBJECTIVE

Against this background the aim of the following assessment is: Based on published scientific literature assess safety, efficacy and effectiveness of minimally-invasive lumbar disc surgery compared to standard procedures. To identify and critically appraise studies comparing costs and cost-effectiveness of minimally-invasive procedures to that of standard procedures. If necessary identify research and evaluation needs and point out regulative needs within the German health care system. The assessment focusses on procedures that are used in elective lumbar disc surgery as alternative treatment options to microdiscectomy or open discectomy. Chemonucleolysis, percutaneous manual discectomy, automated percutaneous lumbar discectomy, laserdiscectomy and endoscopic procedures accessing the disc by a posterolateral or posterior approach are included.

METHODS

In order to assess safety, efficacy and effectiveness of minimally-invasive procedures as well as their economic implications systematic reviews of the literature are performed. A comprehensive search strategy is composed to search 23 electronic databases, among them MEDLINE, EMBASE and the Cochrane Library. Methodological quality of systematic reviews, HTA reports and primary research is assessed using checklists of the German Scientific Working Group for Health Technology Assessment. Quality and transparency of cost analyses are documented using the quality and transparency catalogues of the working group. Study results are summarised in a qualitative manner. Due to the limited number and the low methodological quality of the studies it is not possible to conduct metaanalyses. In addition to the results of controlled trials results of recent case series are introduced and discussed.

RESULTS

The evidence-base to assess safety, efficacy and effectiveness of minimally-invasive lumbar disc surgery procedures is rather limited: PERCUTANEOUS MANUAL DISCECTOMY: Six case series (four after 1998)AUTOMATED PERCUTANEOUS LUMBAR DISCECTOMY: Two RCT (one discontinued), twelve case series (one after 1998)CHEMONUCLEOLYSIS: Five RCT, five non-randomised controlled trials, eleven case seriesPERCUTANEOUS LASERDISCECTOMY: One non-randomised controlled trial, 13 case series (eight after 1998)ENDOSCOPIC PROCEDURES: Three RCT, 21 case series (17 after 1998) There are two economic analyses each retrieved for chemonucleolysis and automated percutaneous discectomy as well as one cost-minimisation analysis comparing costs of an endoscopic procedure to costs for open discectomy. Among all minimally-invasive procedures chemonucleolysis is the only of which efficacy may be judged on the basis of results from high quality randomised controlled trials (RCT). Study results suggest that the procedure maybe (cost)effectively used as an intermediate therapeutical option between conservative and operative management of small lumbar disc herniations or protrusions causing sciatica. Two RCT comparing transforaminal endoscopic procedures with microdiscectomy in patients with sciatica and small non-sequestered disc herniations show comparable short and medium term overall success rates. Concerning speed of recovery and return to work a trend towards more favourable results for the endoscopic procedures is noted. It is doubtful though, whether these results from the eleven and five years old studies are still valid for the more advanced procedures used today. The only RCT comparing the results of automated percutaneous lumbar discectomy to those of microdiscectomy showed clearly superior results of microdiscectomy. Furthermore, success rates of automated percutaneous lumbar discectomy reported in the RCT (29%) differ extremely from success rates reported in case series (between 56% and 92%). The literature search retrieves no controlled trials to assess efficacy and/or effectiveness of laser-discectomy, percutaneous manual discectomy or endoscopic procedures using a posterior approach in comparison to the standard procedures. Results from recent case series permit no assessment of efficacy, especially not in comparison to standard procedures. Due to highly selected patients, modi-fications of operative procedures, highly specialised surgical units and poorly standardised outcome assessment results of case series are highly variable, their generalisability is low. The results of the five economical analyses are, due to conceptual and methodological problems, of no value for decision-making in the context of the German health care system.

DISCUSSION

Aside from low methodological study quality three conceptual problems complicate the interpretation of results. Continuous further development of technologies leads to a diversity of procedures in use which prohibits generalisation of study results. However, diversity is noted not only for minimally-invasive procedures but also for the standard techniques against which the new developments are to be compared. The second problem refers to the heterogeneity of study populations. For most studies one common inclusion criterion was "persisting sciatica after a course of conservative treatment of variable duration". Differences among study populations are noted concerning results of imaging studies. Even within every group of minimally-invasive procedure, studies define their own in- and exclusion criteria which differ concerning degree of dislocation and sequestration of disc material. There is the non-standardised assessment of outcomes which are performed postoperatively after variable periods of time. Most studies report results in a dichotomous way as success or failure while the classification of a result is performed using a variety of different assessment instruments or procedures. Very often the global subjective judgement of results by patients or surgeons is reported. There are no scientific discussions whether these judgements are generalisable or comparable, especially among studies that are conducted under differing socio-cultural conditions. Taking into account the weak evidence-base for efficacy and effectiveness of minimally-invasive procedures it is not surprising that so far there are no dependable economic analyses.

CONCLUSIONS

Conclusions that can be drawn from the results of the present assessment refer in detail to the specified minimally-invasive procedures of lumbar disc surgery but they may also be considered exemplary for other fields where optimisation of results is attempted by technological development and widening of indications (e.g. total hip replacement). Compared to standard technologies (open discectomy, microdiscectomy) and with the exception of chemonucleolysis, the developmental status of all other minimally-invasive procedures assessed must be termed experimental. To date there is no dependable evidence-base to recommend their use in routine clinical practice. To create such a dependable evidence-base further research in two directions is needed: a) The studies need to include adequate patient populations, use realistic controls (e.g. standard operative procedures or continued conservative care) and use standardised measurements of meaningful outcomes after adequate periods of time. b) Studies that are able to report effectiveness of the procedures under everyday practice conditions and furthermore have the potential to detect rare adverse effects are needed. In Sweden this type of data is yielded by national quality registries. On the one hand their data are used for quality improvement measures and on the other hand they allow comprehensive scientific evaluations. Since the year of 2000 a continuous rise in utilisation of minimally-invasive lumbar disc surgery is observed among statutory health insurers. Examples from other areas of innovative surgical technologies (e.g. robot assisted total hip replacement) indicate that the rise will probably continue - especially because there are no legal barriers to hinder introduction of innovative treatments into routine hospital care. Upon request by payers or providers the "Gemeinsamer Bundesausschuss" may assess a treatments benefit, its necessity and cost-effectiveness as a prerequisite for coverage by the statutory health insurance. In the case of minimally-invasive disc surgery it would be advisable to examine the legal framework for covering procedures only if they are provided under evaluation conditions. While in Germany coverage under evaluation conditions is established practice in ambulatory health care only ("Modellvorhaben") examples from other European countries (Great Britain, Switzerland) demonstrate that it is also feasible for hospital based interventions. (ABSTRACT TRUNCATED)

摘要

引言

在因椎间盘突出或膨出而接受腰椎间盘手术的患者中,高达30%的患者预后被判定为不佳。在过去几十年中,这一问题推动了多种微创手术的发展。其目的是通过机械性地移除、溶解或汽化椎间盘物质来减轻受压神经根的压力,同时尽可能保持骨骼结构和周围组织的完整。在德国,这些新手术的使用数据几乎没有——法定医疗保险的数据文件显示,所有腰椎间盘手术中约5%是采用微创技术进行的。其实际比例被认为要高得多,因为许多手术由私立医院和诊所提供,费用由私人健康保险公司或患者自己支付。到目前为止,德国尚未发表过全面评估微创腰椎间盘手术与标准手术(显微椎间盘切除术、开放式椎间盘切除术)的疗效、安全性、有效性和成本效益的报告,而这种评估可为保险覆盖范围决策提供依据。

目的

在此背景下,以下评估的目的是:基于已发表的科学文献,评估微创腰椎间盘手术与标准手术相比的安全性、疗效和有效性。识别并批判性评价比较微创手术与标准手术的成本和成本效益的研究。如有必要,确定研究和评估需求,并指出德国医疗保健系统内的监管需求。该评估聚焦于用于选择性腰椎间盘手术的手术,这些手术是显微椎间盘切除术或开放式椎间盘切除术的替代治疗选择。包括化学髓核溶解术、经皮手动椎间盘切除术、自动经皮腰椎间盘切除术、激光椎间盘切除术以及通过后外侧或后路进入椎间盘的内镜手术。

方法

为了评估微创手术的安全性、疗效和有效性及其经济影响,对文献进行了系统评价。制定了全面的检索策略,以检索23个电子数据库,其中包括MEDLINE、EMBASE和Cochrane图书馆。使用德国卫生技术评估科学工作组的清单评估系统评价、卫生技术评估报告和原始研究的方法学质量。使用该工作组的质量和透明度目录记录成本分析的质量和透明度。研究结果以定性方式进行总结。由于研究数量有限且方法学质量较低,无法进行荟萃分析。除了对照试验的结果外,还引入并讨论了近期病例系列研究的结果。

结果

评估微创腰椎间盘手术安全性、疗效和有效性的证据基础相当有限:经皮手动椎间盘切除术:6个病例系列(4个在1998年之后);自动经皮腰椎间盘切除术:2项随机对照试验(1项中途停止),12个病例系列(1个在1998年之后);化学髓核溶解术:5项随机对照试验,5项非随机对照试验,11个病例系列;经皮激光椎间盘切除术:1项非随机对照试验,13个病例系列(8个在1998年之后);内镜手术:3项随机对照试验,21个病例系列(17个在1998年之后)。检索到化学髓核溶解术和自动经皮椎间盘切除术各有两项经济分析,以及一项将内镜手术成本与开放式椎间盘切除术成本进行比较的成本最小化分析。在所有微创手术中,化学髓核溶解术是唯一一种可根据高质量随机对照试验结果判断疗效的手术。研究结果表明,该手术可作为保守治疗和手术治疗小型腰椎间盘突出或膨出伴坐骨神经痛之间的一种有效(成本效益)中间治疗选择。两项比较经椎间孔内镜手术与显微椎间盘切除术治疗坐骨神经痛和小型非游离性椎间盘突出症患者的随机对照试验显示,短期和中期总体成功率相当。关于恢复速度和重返工作岗位,内镜手术有取得更有利结果的趋势。不过,这些11年和5年前的研究结果对于当今使用的更先进手术是否仍然有效值得怀疑。唯一一项比较自动经皮腰椎间盘切除术与显微椎间盘切除术结果的随机对照试验显示,显微椎间盘切除术的结果明显更优。此外,随机对照试验中报告的自动经皮腰椎间盘切除术成功率(29%)与病例系列中报告的成功率(56%至92%)差异极大。文献检索未找到评估激光椎间盘切除术、经皮手动椎间盘切除术或后路内镜手术与标准手术相比的疗效和/或有效性的对照试验。近期病例系列的结果无法评估疗效,尤其是与标准手术相比时。由于患者选择高度严格、手术操作修改、手术科室高度专业化以及结局评估标准化程度低,病例系列的结果差异很大,其可推广性较低。由于概念和方法学问题,这五项经济分析的结果对于德国医疗保健系统背景下的决策毫无价值。

讨论

除了研究方法学质量较低外,还有三个概念性问题使结果的解释变得复杂。技术的不断发展导致了多种手术方法的使用,这使得研究结果无法一概而论。然而,这种多样性不仅在微创手术中存在,在作为新发展对照的标准技术中也存在。第二个问题涉及研究人群的异质性。对于大多数研究,一个共同的纳入标准是“经过不同时长的保守治疗后持续存在坐骨神经痛”。研究人群在影像学研究结果方面存在差异。即使在每组微创手术中,研究也自行定义其纳入和排除标准,这些标准在椎间盘物质的脱位和游离程度方面存在差异。结局评估未标准化,在术后不同时间段进行。大多数研究以二分法报告结果,即成功或失败,而结果分类使用各种不同的评估工具或程序。通常报告的是患者或外科医生对结果的总体主观判断。对于这些判断是否可推广或可比,尤其是在不同社会文化条件下进行的研究之间,没有科学讨论。考虑到微创手术疗效和有效性的证据基础薄弱,到目前为止没有可靠的经济分析也就不足为奇了。

结论

从本次评估结果中得出的结论详细涉及腰椎间盘手术特定的微创手术,但也可作为其他试图通过技术发展和扩大适应症来优化结果的领域(如全髋关节置换)的范例。与标准技术(开放式椎间盘切除术、显微椎间盘切除术)相比,除化学髓核溶解术外,所有其他评估的微创手术的发展状态都必须被视为实验性的。迄今为止,没有可靠的证据基础推荐在常规临床实践中使用它们。为了建立这样一个可靠的证据基础,需要在两个方向上进行进一步研究:a)研究需要纳入足够的患者群体,使用现实的对照(如标准手术程序或持续的保守治疗),并在适当的时间段后使用标准化的有意义结局测量方法。b)需要能够报告手术在日常实践条件下的有效性并且有潜力检测罕见不良反应的研究。在瑞典,这种类型的数据由国家质量登记处提供。一方面,其数据用于质量改进措施,另一方面,它们允许进行全面的科学评估。自2000年以来,法定医疗保险中微创腰椎间盘手术的使用率持续上升。其他创新手术技术领域(如机器人辅助全髋关节置换)的例子表明,这种上升可能会持续——特别是因为没有法律障碍阻碍将创新治疗引入常规医院护理。应付款方或提供方的要求,“联邦联合委员会”可以评估一种治疗的益处、必要性和成本效益,作为法定医疗保险覆盖的前提条件。对于微创椎间盘手术,仅在评估条件下提供手术时,才建议审查保险覆盖的法律框架。虽然在德国,评估条件下的保险覆盖仅在门诊医疗中是既定做法(“示范项目”),但其他欧洲国家(英国、瑞士)的例子表明,对于基于医院的干预措施也是可行的。(摘要截断)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb94/3011322/4400df3c43de/HTA-01-07-t-001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验